Dr. Mark Basik, a surgical oncologist at the Jewish General Hospital and a senior investigator in the Lady Davis Institute at the JGH, has been appointed President of the Scientific Advisory Committee of the Cancer Research Society.
“Dr. Basik has been a long-time supporter of the Society,” says Dajan O’Donnell, Director of Scientific Affairs and Partnerships. “The Society is honored that he has now agreed to preside over the Scientific Advisory Committee and I look forward to working with him in guiding future scientific direction of the Society.”
Dr. Basik is the Herbert Black Professor of Surgical Oncology at McGill University and a surgical oncologist in the Segal Cancer Centre at the JGH. His medical practice and research are focused on treating breast cancer, especially hard-to-treat breast cancer subtypes.
Dr. Basik uses various models of cancer, such as patient tumour samples, to identify new genes and proteins that may affect key aspects of tumour biology, including the development of resistance to existing treatments.
His research aims to provide critical starting points for the development of novel therapeutics for breast cancer.